Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CADLthis companyCandel Therapeutics, Inc.	$9.41	-7.85×	5.76×	0×	-5.15×	-72.8%	0.0%	0.0%	0.0%	-73.5%	-41.4%	-13.0%	0.04×	3.35×	-22.78×	13.31×	0.0%	2	2.45	1	C-
GNLXGenelux Corporation	$2.02	-5.07×	14.04×	20,261.21×	-5.02×	-100.6%	-7075.0%	-415175.0%	-401812.5%	-278.5%	-251.1%	-16.3%	0.15×	0.12×	0×	2.43×	0.0%	2	-14.59	1	C-
IMMXImmix Biopharma, Inc.	$8.48	-5.88×	1.84×	0×	-2.69×	-63.4%	0.0%	0.0%	0.0%	-31.4%	-31.6%	-14.3%	0.01×	3.14×	0×	10.01×	0.0%	2	35.26	2	C+
INABIN8bio, Inc.	$0.95	-0.53×	0.37×	0×	0.83×	503.4%	0.0%	0.0%	0.0%	-70.5%	-65.5%	-124.2%	0.1×	1.44×	0×	8.82×	0.0%	2	-10.08	3	B-
IOVAIovance Biotherapeutics, Inc.	$8.54	-2.5×	1.4×	3.7×	-2.45×	-50.5%	34.3%	-151.1%	-148.4%	-56.0%	-50.9%	-34.5%	0.07×	0.33×	0×	3.2×	0.0%	4	7.46	2	C
IPSCCentury Therapeutics, Inc.	$1.81	-9.04×	0.54×	0.79×	19.64×	85.0%	88.0%	-13.8%	-8.8%	-6.0%	-7.2%	-121.6%	0.27×	-5.3×	0×	5.97×	0.0%	1	-1.94	2	C
Peer median	—	-5.07×	1.4×	0.79×	-2.45×	-50.5%	0.0%	-13.8%	-8.8%	-56.0%	-50.9%	-34.5%	0.1×	0.33×	0×	5.97×	0.0%	2	-1.94	2	—